Cannabinoid Rich Chemotypes

Cannabinoid-rich chemotypes refer to cannabis plants bred to express elevated levels of specific cannabinoids—typically CBD, CBG, CBN, or minor cannabinoids—beyond the minor presence found in standard cannabis genetics. These phenotypes result from selective breeding practices targeting terpene and cannabinoid synthase expression patterns, rather than THC dominance. Cannabinoid-rich lines are often derived from hemp genetics, landrace populations with natural cannabinoid diversity, or deliberate crosses designed to amplify non-THC pathways. Lineage records frequently report that breeders working in this category prioritize chemotype stability across generations, using lab testing to confirm cannabinoid ratios before selection. This classification encompasses a wide range of potential ratios—from CBD:THC expressions to pure CBD or CBG-dominant plants—making it essential for breeding progr

Breeders use cannabinoid-rich chemotypes as foundational genetics for creating stable cultivars with predictable cannabinoid profiles. These lines enable crossing programs aimed at developing novel ratios, preserving rare cannabinoid phenotypes, and establishing seed stock for regulated agricultural production.